APGN — Apexigen Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $12.20m
- $2.83m
Annual cashflow statement for Apexigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -24.1 | -28.9 | -32.1 |
| Depreciation | |||
| Non-Cash Items | 2.3 | 1.88 | 3.28 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.74 | 3.03 | -2.01 |
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -20 | -23.9 | -30.7 |
| Capital Expenditures | 0 | -0.054 | -0.057 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -24.2 | 22.1 | 11 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | -24.2 | 22 | 11 |
| Financing Cash Flow Items | -0.28 | -0.061 | -9.61 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Cash from Financing Activities | 12.9 | 0.037 | 11.1 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -31.2 | -1.84 | -8.64 |